BioNTech in China alliance with Fosun over potential coronavirus vaccine

FRANKFURT (Reuters) – BioNTech struck a collaboration deal with Shanghai Fosun Pharmaceutical over the German biotech firm’s rights in China to an experimental coronavirus vaccine, the latest gambit in a global race to halt the pandemic. Once regulators approv... More »